Caroline Litchfield
Director of Finance/CFO en IMMUNE DESIGN CORP .
Fortuna: 7 M $ al 31/03/2024
Cargos activos de Caroline Litchfield
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
IMMUNE DESIGN CORP | Director/Board Member | 02/04/2019 | - |
Director of Finance/CFO | - | - | |
Treasurer | 02/04/2019 | - | |
MERCK & CO., INC. | Director of Finance/CFO | 01/04/2021 | - |
Treasurer | 01/01/2018 | 01/04/2021 |
Historial de carrera de Caroline Litchfield
Antiguos cargos conocidos de Caroline Litchfield.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ORGANON & CO. | Director/Board Member | - | 31/05/2021 |
FULFORD (INDIA) LIMITED | Director/Board Member | 04/08/2013 | 30/01/2014 |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Director of Finance/CFO | - | 23/06/2009 |
Formación de Caroline Litchfield.
University of Leicester | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 4 |
Reino Unido | 3 |
India | 2 |
Operativa
Director of Finance/CFO | 3 |
Director/Board Member | 3 |
Treasurer | 2 |
Sectorial
Health Technology | 6 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
ORGANON & CO. | Health Technology |
Empresas privadas | 3 |
---|---|
Fulford (India) Ltd.
Fulford (India) Ltd. Pharmaceuticals: MajorHealth Technology Fulford (India) Ltd. engages in the wholesale of pharmaceutical and medical goods. Its products include speciality health care and fertility, oncology, quadriderm, elocon, elosalic, dipsalic, and emolene. The company was founded on March 2, 1948 and is headquartered in Mumbai, India. | Health Technology |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
Immune Design Corp.
Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Caroline Litchfield
- Experiencia